137 related articles for article (PubMed ID: 8950073)
1. Hemodynamic effects of intravenous elgodipine in coronary artery disease during rest and exercise, and basic pharmacokinetic parameters.
Silke B; de la Motte S; Spiers P; Herity NA; Drake M; Kelly J; Harrison FJ
Cardiovasc Drugs Ther; 1996 Nov; 10(5):573-80. PubMed ID: 8950073
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
Kuhn A; Carlsson J; Miketic S; Tebbe U
Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
[TBL] [Abstract][Full Text] [Related]
3. Anti-ischaemic and haemodynamic effects of elgodipine, a potent new generation calcium antagonist, in chronic stable angina.
Acharya DU; Senior R; Basu S; Harrison F; Galiano A; Lahiri A
Eur Heart J; 1994 May; 15(5):665-71. PubMed ID: 8056008
[TBL] [Abstract][Full Text] [Related]
4. An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
Silke B; Goldhammer E; Sharma SK; Verma SP; Taylor SH
Cardiovasc Drugs Ther; 1990 Apr; 4(2):457-63. PubMed ID: 2149514
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
Drieu la Rochelle CD; Grosset A; O'Connor SE
Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724
[TBL] [Abstract][Full Text] [Related]
6. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
Sassen LM; Soei LK; Koning MM; Verdouw PD
Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
[TBL] [Abstract][Full Text] [Related]
7. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina.
Saito T; Fujii K; Takizawa T; Toyosaki T; Kuwabara Y; Kobayashi S; Ichikawa H; Karaki A; Yamazaki Y; Iwata J; Yamada K; Tomiya H; Takeda K; Inagaki Y
Arzneimittelforschung; 1996 Sep; 46(9):861-7. PubMed ID: 8876934
[TBL] [Abstract][Full Text] [Related]
8. [Effect of intravenous diltiazem on stress-induced myocardial ischemia (study of hemodynamics and reproducibility of repeated studies].
Schnellbacher K; Hirsch F; Stengele E; Roskamm H
Z Kardiol; 1988 Jan; 77(1):36-43. PubMed ID: 3284218
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist.
Burger W; Neidel S; Kober G
Clin Cardiol; 1989 Jul; 12(7):393-8. PubMed ID: 2525975
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral isradipine on left ventricular function at rest and during exercise in patients with stable chronic angina: a double-blind, placebo-controlled crossover study.
Delonca J; Kipfer P; Righetti A
J Cardiovasc Pharmacol; 1992 Jan; 19(1):126-33. PubMed ID: 1375679
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of the new dihydropyridine derivative elgodipine.
Tamargo J; López-Sendón J; Delpón E; González-Morales M; de Miguel E
Arzneimittelforschung; 1991 Sep; 41(9):895-900. PubMed ID: 1796916
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.
Detry JM; De Coster PM; Renkin J
Am J Cardiol; 1983 Sep; 52(5):453-7. PubMed ID: 6613867
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
[TBL] [Abstract][Full Text] [Related]
15. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH
Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic actions of bepridil during treatment of stable angina pectoris.
Narahara KA; Shapiro W; Weliky I; Park J
Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742
[TBL] [Abstract][Full Text] [Related]
17. Effects of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris.
Yokota M; Tsunekawa A; Miyahara T; Kamihara S; Kitamura J; Noda S; Koide M; Tsuzuki M; Sotobata I
Am J Cardiol; 1986 Jul; 58(1):53-8. PubMed ID: 3728331
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
Silke B; Verma SP; Zezulka AV; Sharma S; Reynolds G; Jackson NC; Guy S; Taylor SH
Br J Clin Pharmacol; 1990 Apr; 29(4):437-45. PubMed ID: 2139339
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
